Identifying miR‑431‑5p as a biomarker for early‑onset severe preeclampsia through integrated bioinformatic and clinical analyses


Abstract

Background. Early-onset severe preeclampsia (EOSPE) is a serious pregnancy complication leading to adverse maternal and neonatal outcomes. This study aimed to identify potential diagnostic biomarkers for EOSPE and to investigate their clinical significance.

Methods. MicroRNAs (miRNAs) expression datasets from the Gene Expression Omnibus(GEO)database—specifically, placental tissue (GSE103542) and plasma (GSE234611)—were screened to identify miRNAs that are consistently dysregulated in early-onset preeclampsia (EOPE). We aim to discover strong biomarker candidates. We employed Weighted Gene Co-expression Network Analysis(WGCNA)to identify key modules associated with preeclampsia (PE). Functional enrichment analysis predicted target genes and involved pathways. Clinical samples (serum and placental tissues from EOSPE patients and normal pregnant women) and a Lipopolysaccharide (LPS)-induced preeclampsia rat model were utilized to validate the expression of the differentially expressed miRNAs (DEmiRNAs) using Reverse Transcription Quantitative Polymerase Chain Reaction(RT-qPCR). Its diagnostic value was evaluated by Receiver Operating Characteristic(ROC)curve analysis, and its correlation with clinical parameters was assessed.

Results. Bioinformatics analysis identified miR-431-5p as a key molecule, with its expression significantly upregulated in both serum and placental tissues of EOSPE patients. Circulating miR-431-5p shows promising diagnostic potential for EOSPE. Its expression level positively correlated with systolic(r =0.395,P=0.017)and diastolic blood pressure(r =0.41,P=0.013), uric acid(r =0.389,P=0.02), lactate dehydrogenase(r =0.399,P=0.018), and the umbilical artery S/D ratio(r =0.457,P=0.01), and negatively correlated with gestational age at delivery (r = -0.562,P<0.001)and neonatal birth weight(r = -0.503,P=0.02). Animal experiments confirmed similar upregulation of miR-431-5p in the LPS-induced preeclampsia rat model.

Conclusions. miR-431-5p is specifically highly expressed in EOSPE, possesses good diagnostic value, and its expression level correlates with disease severity, suggesting its potential as a novel molecular marker for the early diagnosis and assessment of EOSPE.

Ask to review this manuscript

Notes for potential reviewers

  • Volunteering is not a guarantee that you will be asked to review. There are many reasons: reviewers must be qualified, there should be no conflicts of interest, a minimum of two reviewers have already accepted an invitation, etc.
  • This is NOT OPEN peer review. The review is single-blind, and all recommendations are sent privately to the Academic Editor handling the manuscript. All reviews are published and reviewers can choose to sign their reviews.
  • What happens after volunteering? It may be a few days before you receive an invitation to review with further instructions. You will need to accept the invitation to then become an official referee for the manuscript. If you do not receive an invitation it is for one of many possible reasons as noted above.

  • PeerJ does not judge submissions based on subjective measures such as novelty, impact or degree of advance. Effectively, reviewers are asked to comment on whether or not the submission is scientifically and technically sound and therefore deserves to join the scientific literature. Our Peer Review criteria can be found on the "Editorial Criteria" page - reviewers are specifically asked to comment on 3 broad areas: "Basic Reporting", "Experimental Design" and "Validity of the Findings".
  • Reviewers are expected to comment in a timely, professional, and constructive manner.
  • Until the article is published, reviewers must regard all information relating to the submission as strictly confidential.
  • When submitting a review, reviewers are given the option to "sign" their review (i.e. to associate their name with their comments). Otherwise, all review comments remain anonymous.
  • All reviews of published articles are published. This includes manuscript files, peer review comments, author rebuttals and revised materials.
  • Each time a decision is made by the Academic Editor, each reviewer will receive a copy of the Decision Letter (which will include the comments of all reviewers).

If you have any questions about submitting your review, please email us at [email protected].